Katya Govender

453 total citations
16 papers, 235 citations indexed

About

Katya Govender is a scholar working on Infectious Diseases, Virology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Katya Govender has authored 16 papers receiving a total of 235 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 6 papers in Virology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Katya Govender's work include HIV Research and Treatment (6 papers), HIV/AIDS Research and Interventions (6 papers) and HIV/AIDS drug development and treatment (6 papers). Katya Govender is often cited by papers focused on HIV Research and Treatment (6 papers), HIV/AIDS Research and Interventions (6 papers) and HIV/AIDS drug development and treatment (6 papers). Katya Govender collaborates with scholars based in South Africa, United States and United Kingdom. Katya Govender's co-authors include John Adamson, Lubbe Wiesner, Paolo Denti, Du Plessis, Anushka Naidoo, Maxwell Chirehwa, Helen McIlleron, Kogieleum Naidoo, Nonhlanhla Yende‐Zuma and Nesri Padayatchi and has published in prestigious journals such as PLoS Pathogens, AIDS and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Katya Govender

16 papers receiving 232 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katya Govender South Africa 10 110 62 50 39 38 16 235
Marga Teulen Netherlands 8 179 1.6× 78 1.3× 30 0.6× 25 0.6× 37 1.0× 12 290
Rita de Cássia Elias Estrela Brazil 10 159 1.4× 41 0.7× 53 1.1× 34 0.9× 42 1.1× 20 283
Julius O. Soyinka Nigeria 12 101 0.9× 37 0.6× 17 0.3× 69 1.8× 49 1.3× 32 294
Florence Marzan United States 10 224 2.0× 132 2.1× 34 0.7× 96 2.5× 51 1.3× 19 367
L. Trentini Italy 11 257 2.3× 78 1.3× 137 2.7× 28 0.7× 35 0.9× 25 354
Stephen Walimbwa Uganda 6 156 1.4× 33 0.5× 77 1.5× 20 0.5× 20 0.5× 12 230
Sujan Dilly Penchala United Kingdom 13 234 2.1× 73 1.2× 56 1.1× 81 2.1× 48 1.3× 22 365
Aaron M. Teitelbaum United States 11 113 1.0× 65 1.0× 70 1.4× 9 0.2× 124 3.3× 24 385
Aleksandrs Odinecs United States 8 74 0.7× 22 0.4× 44 0.9× 53 1.4× 42 1.1× 11 231
Justin Chiong United Kingdom 7 73 0.7× 21 0.3× 42 0.8× 23 0.6× 30 0.8× 11 191

Countries citing papers authored by Katya Govender

Since Specialization
Citations

This map shows the geographic impact of Katya Govender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katya Govender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katya Govender more than expected).

Fields of papers citing papers by Katya Govender

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katya Govender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katya Govender. The network helps show where Katya Govender may publish in the future.

Co-authorship network of co-authors of Katya Govender

This figure shows the co-authorship network connecting the top 25 collaborators of Katya Govender. A scholar is included among the top collaborators of Katya Govender based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katya Govender. Katya Govender is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Dorward, Jienchi, Katya Govender, Pravi Moodley, et al.. (2023). Urine tenofovir and dried blood spot tenofovir diphosphate concentrations and viraemia in people taking efavirenz and dolutegravir-based antiretroviral therapy. AIDS. 38(5). 697–702. 1 indexed citations
2.
Řezníčková, Eva, et al.. (2023). Design and synthesis of novel 1,2,4-triazolo[4,3-b]pyridazine derivatives with anti-cancer activity. Journal of Molecular Structure. 1291. 135938–135938. 6 indexed citations
3.
McCluskey, Suzanne M., Katya Govender, John Adamson, et al.. (2023). Point-of-care urine tenofovir testing to predict HIV drug resistance among individuals with virologic failure. AIDS. 37(7). 1109–1113. 12 indexed citations
4.
Dorward, Jienchi, Richard Lessells, Katya Govender, et al.. (2023). Diagnostic accuracy of a point‐of‐care urine tenofovir assay, and associations with HIV viraemia and drug resistance among people receiving dolutegravir and efavirenz‐based antiretroviral therapy. Journal of the International AIDS Society. 26(9). e26172–e26172. 5 indexed citations
5.
Ahmed, Mohamed I. M., Jared S. Mackenzie, Liku B. Tezera, et al.. (2022). Mycobacterium tuberculosis senses host Interferon-γ via the membrane protein MmpL10. Communications Biology. 5(1). 1317–1317. 11 indexed citations
6.
Kemp, Steven A., Oscar Charles, Anne Derache, et al.. (2022). HIV-1 Evolutionary Dynamics under Nonsuppressive Antiretroviral Therapy. mBio. 13(3). e0026922–e0026922. 4 indexed citations
7.
Lustig, Gila, Sandile Cele, Farina Karim, et al.. (2021). T cell derived HIV-1 is present in the CSF in the face of suppressive antiretroviral therapy. PLoS Pathogens. 17(9). e1009871–e1009871. 28 indexed citations
8.
Singh, Alveera, Kavidha Reddy, Ntombifuthi Mthabela, et al.. (2021). Irreversible depletion of intestinal CD4+ T cells is associated with T cell activation during chronic HIV infection. JCI Insight. 6(22). 15 indexed citations
9.
Liebenberg, Lenine J. P., Sinaye Ngcapu, Alasdair Leslie, et al.. (2021). Genital and systemic immune effects of the injectable, contraceptive norethisterone enanthate (NET‐EN), in South African women. American Journal of Reproductive Immunology. 86(2). e13411–e13411. 2 indexed citations
10.
Liebenberg, Lenine J. P., Alasdair Leslie, Laura Noël‐Romas, et al.. (2020). Plasma concentration of injectable contraceptive correlates with reduced cervicovaginal growth factor expression in South African women. Mucosal Immunology. 13(3). 449–459. 16 indexed citations
11.
Naidoo, Anushka, Maxwell Chirehwa, Veron Ramsuran, et al.. (2019). Effects of Genetic Variability on Rifampicin and Isoniazid Pharmacokinetics in South African Patients with Recurrent Tuberculosis. Pharmacogenomics. 20(4). 225–240. 38 indexed citations
12.
Govender, Katya, John Adamson, & Peter M. O. Owira. (2018). The development and validation of a LC-MS/MS method for the quantitation of metformin, rifampicin and isoniazid in rat plasma using HILIC chromatography. Journal of Chromatography B. 1095. 127–137. 13 indexed citations
13.
Naidoo, Anushka, Maxwell Chirehwa, Helen McIlleron, et al.. (2017). Effect of rifampicin and efavirenz on moxifloxacin concentrations when co-administered in patients with drug-susceptible TB. Journal of Antimicrobial Chemotherapy. 72(5). 1441–1449. 27 indexed citations
14.
Plessis, Du, Katya Govender, Paolo Denti, & Lubbe Wiesner. (2015). In vivo efficacy and bioavailability of lumefantrine: Evaluating the application of Pheroid technology. European Journal of Pharmaceutics and Biopharmaceutics. 97(Pt A). 68–77. 27 indexed citations
15.
Govender, Katya, Liezl Gibhard, Du Plessis, & Lubbe Wiesner. (2015). Development and validation of a LC–MS/MS method for the quantitation of lumefantrine in mouse whole blood and plasma. Journal of Chromatography B. 985. 6–13. 9 indexed citations
16.
Wiesner, Lubbe, Katya Govender, Sandra Meredith, Jennifer Norman, & Peter J. Smith. (2011). A liquid–liquid LC/MS/MS assay for the determination of artemether and DHA in malaria patient samples. Journal of Pharmaceutical and Biomedical Analysis. 55(2). 373–378. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marga Teulen Breakdown of academic impact, for papers by Rita de Cássia Elias Estrela Breakdown of academic impact, for papers by Julius O. Soyinka Breakdown of academic impact, for papers by Florence Marzan Breakdown of academic impact, for papers by L. Trentini Breakdown of academic impact, for papers by Stephen Walimbwa Breakdown of academic impact, for papers by Sujan Dilly Penchala Breakdown of academic impact, for papers by Aaron M. Teitelbaum Breakdown of academic impact, for papers by Aleksandrs Odinecs Breakdown of academic impact, for papers by Justin Chiong
Rankless by CCL
2026